PhageTech Secures $2,400,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    4 Corporate Plaza Newport Beach, CA 92660 USA
  • Company Description
    PhageTech, Inc. is a California based development stage company with an innovative platform that employs a bacteriophage substrate for detecting analytes in urine, blood and most any other body fluid. This technology promises to offer equal or better performance against antibody based assays.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds will be used to complete development and FDA clearance of its revolutionary PhageTech Biosensor technology.
  • M&A Terms
  • Venture Investor
    Mark IV Capital
  • Venture Investor
    Black River Asset Management

Trending on Xconomy